Ana Maria Henao

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Experience in global measles control, 1990-2001
    Ana Maria Henao-Restrepo
    Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    J Infect Dis 187:S15-21. 2003
  2. doi request reprint Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
    Ana Maria Henao-Restrepo
    WHO, Geneva, Switzerland Electronic address
    Lancet . 2016
  3. pmc Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
    Raymond Hutubessy
    Initiative for Vaccine Research, Immunization, Biologicals and Vaccines Department, World Health Organization, 20 Avenue Appia, CH 1210 Geneva, Switzerland
    BMC Med 9:55. 2011
  4. pmc Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
    Nathorn Chaiyakunapruk
    Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    BMC Med 9:53. 2011
  5. ncbi request reprint Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts
    Alejandro Costa
    Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    J Infect Dis 187:S22-8. 2003
  6. ncbi request reprint Global measles elimination efforts: the significance of measles elimination in the United States
    Peter M Strebel
    Global Immunization Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 189:S251-7. 2004

Collaborators

  • Marie Paule Kieny
  • Godwin Enwere
  • Ira M Longini
  • Alejandro Costa
  • Mark Papania
  • P Strebel
  • Ana Maria Henao-Restrepo
  • Raymond Hutubessy
  • Joachim Hombach
  • Nathorn Chaiyakunapruk
  • Matthias Egger
  • Miles W Carroll
  • Natalie E Dean
  • Ibrahima Diatta
  • Pierre Stéphane Gsell
  • Sakoba Keita
  • Stefanie Hossmann
  • Andrea S Vicari
  • Sema Mandal
  • Souleymane Kone
  • John Arne Røttingen
  • Sophie Duraffour
  • Rebecca Grais
  • Aboubacar Soumah
  • Myron M Levine
  • Moussa Doumbia
  • Sven Trelle
  • Bertrand Draguez
  • Conall H Watson
  • Stephan Gunther
  • Thomas Mauget
  • Eewa Kuisma
  • W John Edmunds
  • Mandy Kader Kondé
  • Ximena Riveros
  • Sara Viksmoen Watle
  • Gunnstein Norheim
  • Anton Camacho
  • John W Edmunds
  • Pem Namgyal
  • Ratchadaporn Somkrua
  • Philippe Beutels
  • Vasee Moorthy
  • Alessia Melegaro
  • Edward John Hoekstra
  • Julian Bilous
  • Maureen Birmingham

Detail Information

Publications6

  1. ncbi request reprint Experience in global measles control, 1990-2001
    Ana Maria Henao-Restrepo
    Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    J Infect Dis 187:S15-21. 2003
    ..Current systems for monitoring measles vaccination coverage and disease burden must be improved to accurately assess progress toward measles control goals...
  2. doi request reprint Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
    Ana Maria Henao-Restrepo
    WHO, Geneva, Switzerland Electronic address
    Lancet . 2016
    ..We tested the effect of rVSV-ZEBOV in preventing Ebola virus disease in contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa...
  3. pmc Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
    Raymond Hutubessy
    Initiative for Vaccine Research, Immunization, Biologicals and Vaccines Department, World Health Organization, 20 Avenue Appia, CH 1210 Geneva, Switzerland
    BMC Med 9:55. 2011
    ....
  4. pmc Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
    Nathorn Chaiyakunapruk
    Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    BMC Med 9:53. 2011
    ..With the aim to guide policymakers on their optimal use, we compared publicly available decision-making tools in relation to their methods, influential parameters and results...
  5. ncbi request reprint Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts
    Alejandro Costa
    Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    J Infect Dis 187:S22-8. 2003
    ..WHO and UNICEF, with major partners, will review progress on measles mortality reduction and assess the feasibility of global measles eradication. Strong collaboration by all key stakeholders will be invaluable...
  6. ncbi request reprint Global measles elimination efforts: the significance of measles elimination in the United States
    Peter M Strebel
    Global Immunization Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 189:S251-7. 2004
    ..This experience provides evidence that sustained interruption of transmission can be achieved in large geographic areas, suggesting the feasibility of global eradication of measles...